Long Daniel D.
CIK 2040349 · SVP, Drug Discovery · last filed 2026-02-10
Long Daniel D. is a SVP, Drug Discovery who has filed 3 SEC Form 4 insider transactions across 1 company since 2025. The most recent filing, for SEPN, was dated Feb 10, 2026. Across all open-market trades the lifetime net is −$63.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.88M
1
3
-$63.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SEPN | SVP, Drug Discovery | 92,911 | $31.01 | $2.88M | -$63.2K | 3 | 2026-02-10 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-10 | SEPN | Grant (A) | — | $0 | EDGAR |
| 2025-11-13 | SEPN | Sell (S) | −3,501 | -$63.2K | EDGAR |
| 2025-08-11 | SEPN | Grant (A) | — | $0 | EDGAR |